The middle of July delivered the kind of week that reshuffles dockets. A federal appeals court put a mass tort that most defense-side observers had written off back on the board, the government pressed an aggressive offset theory that could shrink thousands of toxic-exposure recoveries, and a regulatory purge that has been building for eighteen months started surfacing as liability evidence in trucking cases. Here is what personal injury practitioners should track coming out of the week of July 13.
The Tylenol MDL is a live tort again
On July 13, a unanimous Second Circuit panel vacated the exclusion of three of the plaintiffs' general-causation experts in the acetaminophen autism and ADHD MDL and revived more than 500 cases that had been dismissed after the district court's earlier gatekeeping ruling. The reinstated experts include Dr. Andrea Baccarelli, dean of the Harvard T.H. Chan School of Public Health, psychiatrist Dr. Eric Hollander, and Columbia toxicologist Dr. Brandon Pearson. The panel held that the district court had gone too far in treating disagreement among scientists as a reason to keep the testimony from a jury, reasoning that the challenged methods reflected approaches other researchers use and amounted to acceptable interpretations of the evidence.
The court was careful about what it did not decide. The opinion does not hold that prenatal acetaminophen causes autism or ADHD, and the plaintiffs still have to prove general and specific causation to the finder of fact. The cases now return to Judge Denise Cote in the Southern District of New York, where the litigation restarts with a very different posture than it had a month ago. Two developments give the plaintiffs more than they had before: a unanimous appellate opinion endorsing their experts' methodology, and the FDA's late-2025 move toward pregnancy-related labeling language for acetaminophen, which plaintiffs will cite as evidence the risk was recognized.
For firms weighing intake, the practical signal is caution rather than a green light. Reinstated experts survive a gatekeeping challenge; they do not win the case. But an MDL that was effectively dead now has a functioning causation record, and the retailer and manufacturer defendants face renewed pressure to value the inventory. Expect a scramble to refile and preserve claims, and expect the defense to seek rehearing en banc or certiorari before the reconstituted docket gains momentum. Our product liability coverage will track the causation fight as it returns to SDNY.
Camp Lejeune: the fight has moved to the math
The Camp Lejeune Justice Act litigation in the Eastern District of North Carolina has passed the threshold questions and reached the accounting. More than 3,700 cases are on file, with hundreds of thousands of administrative claims still pending with the Department of the Navy. The dispute now drawing the most attention is a benefit-offset question that will determine what plaintiffs actually collect.
The government's position is that the statute requires courts to subtract any VA, Medicare, or Medicaid benefits tied to the claimant's Camp Lejeune exposure from any award entered at trial. Plaintiffs read the offset far more narrowly. The stakes are enormous in the aggregate: a broad reading would claw back a substantial share of the collateral benefits many of these claimants have received over decades of illness, and it would do so across the entire inventory at once. However the court rules, the outcome will feed directly into settlement valuation, because the parties cannot price the docket until they know whether recoveries are gross or net of federal benefits.
The offset fight also carries a lesson that travels beyond this one statute. Collateral-source and government-benefit offsets are becoming a primary battleground in large-inventory litigation, and the number a client keeps increasingly depends on lien and offset mechanics rather than on the verdict headline. Firms handling these claims should be modeling net recovery under both readings now, not after a ruling lands.
The Clearinghouse purge becomes trucking evidence
A regulatory change that has been accumulating quietly since late 2024 is now surfacing in crash litigation. The FMCSA Drug and Alcohol Clearinghouse recorded more than 320,000 CDL and CLP holders with at least one violation as of early 2026, with roughly 202,000 in prohibited status. Since November 2024, state licensing agencies have been required to downgrade the commercial license of any driver in prohibited status, generally within 60 days, which turns a database entry into a hard loss of driving privileges.
For plaintiff counsel, that machinery produces clean liability facts. A carrier that failed to run a required Clearinghouse query, or that received a prohibited-status alert and left the driver on the road, has handed the plaintiff a negligent-hiring or negligent-retention case that does not depend on parsing the crash itself. That theory is already showing up in verdicts. A Florida jury in late 2025 reportedly returned $141.5 million, most of it punitive, in a case where the carrier had received a prohibited-status flag and did nothing with it. Whether that award holds through post-trial review or not, it reflects how juries are treating documented, ignored safety signals. Our truck and motorcycle coverage goes deeper on the driver-qualification-file discovery these cases turn on.
Tort reform, one year in
The 2025 wave of state tort reform is now old enough to have a track record, and Georgia is the clearest test case. Senate Bills 68 and 69, signed in April 2025, eliminated the state's phantom-damages practice by tying recoverable medical expenses to amounts actually paid or reasonably expected to be paid rather than the full billed charge, a change practitioners estimate can cut medical specials by 30 to 50 percent in some cases. The same package lifted the longstanding bar on seatbelt-nonuse evidence and tightened the rules on anchoring arguments for non-economic damages.
A year of practice under those rules is producing adaptation rather than retreat. Plaintiff firms are documenting the reasonable value of care more carefully, front-loading the billing-and-payment record, and preparing for seatbelt evidence as a routine part of auto trials rather than an exception. The broader point for the plaintiff bar is that the reform states now demand a different case build from the reform-free states, and firms operating across state lines are effectively running two playbooks.
The phantom-damages change is also pushing more firms toward lien-based treatment relationships, because the amount actually paid or reasonably expected to be paid becomes the ceiling on recoverable specials. When a provider bills through a letter of protection at a documented, defensible rate, that figure is harder for the defense to attack as inflated than a full chargemaster number discounted by a private insurer. The counseling point at intake is that the medical-billing decision now shapes the damages model from day one, and the staff tracking provider bills need to capture the paid-or-payable figure, not just the billed amount, from the first statement forward.
What we are watching
- Whether the acetaminophen defendants seek rehearing en banc or Supreme Court review before the SDNY docket reactivates in earnest.
- The Camp Lejeune offset ruling, which will reset settlement math across the entire EDNC inventory.
- Post-trial motions on the recent trucking punitive awards, which will show how much of the nuclear-verdict trend survives judicial review.
- The next round of state tort-reform data as Georgia and its peers move past their first full year.
The connective thread this week is that the money question is migrating away from liability and toward what a plaintiff actually keeps. Causation gatekeeping, benefit offsets, phantom-damages limits, and punitive review are all fights over the net number. For ongoing coverage of these developments, follow our industry news desk.